Delivery Order SPE2DB22D3004-SPE2DB25FSD36
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pediarix HIB vaccine in 0.5 milliliter vials, with a ceiling value of $1,326.85 and an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under the company's larger...
- The Defense Logistics Agency awarded a $4,949.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Pediarix HIB vaccine in 0.5mL vials. Issued on August 11, 2025, with an ultimate completion date of August 12, 2025, this competitively awarded contract (no set-aside used) will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,164.10 on August 12, 2025, for the supply of Pediarix HIB vaccine in 0.5mL vials. This contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract is...
- The Defense Logistics Agency awarded a delivery order valued at $5,206.60 to AmerisourceBergen Drug Corp for the supply of Pediarix HIB vaccine in 0.5 milliliter vials. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,237.16 to AmerisourceBergen Drug Corp for the supply of Pediarix HIB vaccine in 0.5ML vials. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and no set-aside designation was used in the award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's extensive pharmaceutical distribution capabilities and...
- The U.S. Defense Logistics Agency awarded a $3,663.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pediarix vaccine vials (0.5mL) on August 7, 2025, with completion expected by August 8, 2025. This is a competitive award with no set-aside designation, representing a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,115.70 to AmerisourceBergen Drug Corp for the supply of Pediarix HIB vaccine in 0.5ML vials. The contract, which was competitively awarded with no set-aside designation, carries a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Pediarix/PedvaxHIB vaccine in 0.5 mL vials, with a ceiling value of $3,791.80 and an ultimate completion date of May 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a pediatric immunization product delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Pediarix (Hib) vaccine in 0.5 mL vials, with a ceiling value of $1,324.88 and an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Pediarix HB vaccine in 0.5 mL vials with a ceiling value of $1,137.54. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle. The award was made on a competitive basis without any set-aside designation, and performance will be...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSD36Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Pediarix HIB vaccine in 0.5ML vials, with a ceiling value of $1,938.38. This firm fixed price delivery order, which is due for completion by August 26, 2025, represents a competitively awarded non-set-aside contract supporting federal medical procurement needs. The order will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate operations as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive $999.99 billion prime vendor vehicle valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible procurement mechanisms that facilitate access to vaccines, medications, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/25/25 |